|
Resiquimod
- 英文名称：Resiquimod
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B10790
- cas：144875-48-9
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-12-08
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B10790 |
| 用途 | 科研检测 |
| 英文名称 | Resiquimod |
| 包装规格 | 1MG |
| CAS编号 | 144875-48-9 |
| 别名 | Resiquimod |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by TLC,;NMR (Conforms)
分子式:C17H22N4O2
分子量:314-38
溶剂:DMSO (30 mg/ml) Ethanol (15 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):TLR7/8 agonist / Immune adjuvant
Function / Pharmacology:A Toll-like receptor 7/8 agonist.1 May be used as an immune adjuvant in cancer vaccines.2 Resiquimod-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.3 Topical treatment of wild-type mice induces systemic autoimmune disease which may be used as a model of systemic Lupus erythematosus.4
分子式:C17H22N4O2
分子量:314-38
溶剂:DMSO (30 mg/ml) Ethanol (15 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):TLR7/8 agonist / Immune adjuvant
Function / Pharmacology:A Toll-like receptor 7/8 agonist.1 May be used as an immune adjuvant in cancer vaccines.2 Resiquimod-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.3 Topical treatment of wild-type mice induces systemic autoimmune disease which may be used as a model of systemic Lupus erythematosus.4
